Immusoft

OverviewSuggest Edit

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of its Immune System Programming technology were licensed by Immusoft.
TypePrivate
Founded2009
HQSeattle, WA, USMap
Websiteimmusoft.com

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2021)15
Cybersecurity ratingCMore

Key People/Management at Immusoft

Wendell King

Wendell King

Board Member
Matthew Scholz

Matthew Scholz

Founder, Board Member
Sean Ainsworth

Sean Ainsworth

Chief Executive Officer
Show more

Immusoft Office Locations

Immusoft has an office in Seattle
Seattle, WA, US (HQ)
454 N 34th St
Show all (1)

Immusoft Financials and Metrics

Summary Metrics

Founding Date

2009

Immusoft total Funding

$9.4 m

Immusoft latest funding size

$3.60 m

Time since last funding

3 years ago

Immusoft investors

Founders Fund, Peter Thiel, Tim Draper, FF Science, Breakout Ventures, Westcott LLC, The Thiel Foundation, Technium Partners, 600 Mile Challenge Fund
Immusoft's latest funding round in January 2018 was reported to be $3.6 m. In total, Immusoft has raised $9.4 m
Show all financial metrics

Immusoft Cybersecurity Score

Cybersecurity ratingPremium dataset

C

75/100

Learn more about our premium products
SecurityScorecard logo

Immusoft Online and Social Media Presence

Immusoft's Trends

Embed Graph

Immusoft Blogs

May 12, 2020

Immusoft to Present at ASGCT 23rd Annual Meeting

– Two presentations to highlight the transposon-engineered B lymphocytes ISP™ platform for MPS I and enhancement of muscle mass – Seattle, Wash.–(BUSINESS WIRE) –May 12, 2020– Immusoft Corporation, a Seattle-Wash.-based, leading cell therapy company, today announced two upcoming virtual oral present…
February 05, 2020

Immusoft to Present at WORLDSymposium™ 2020

– Dr. McIvor, Chief Development Officer, to present on the Sleeping Beauty-Engineered B Lymphocytes ISP™ platform – Seattle, Wash.–(BUSINESS WIRE) –February 5, 2020– Immusoft Corporation, a Seattle-Wash.-based, leading cell therapy company, today announced that Scott McIvor, Ph.D., Chief Development…
September 10, 2019

Immusoft to Present at the International Conference on Lymphocyte Engineering 2019

Dr. McIvor, Chief Development Officer, to present on the Sleeping Beauty-Engineered B Lymphocytes ISP™ platform The post Immusoft to Present at the International Conference on Lymphocyte Engineering 2019 appeared first on Immusoft.
July 17, 2019

Immusoft Announces the Appointment of Robert Hayes, Ph.D. as Chief Scientific Officer

Seattle, Wash.–(BUSINESS WIRE) –July17,2019–Immusoft Corporation, a Seattle-Wash.-based, leading cell therapy company, today announced the appointment of Robert Hayes, Ph.D., as Chief Scientific Officer. With nearly two decades of biologics discovery and development experience, Dr. Hayes will lead I…

 Immusoft Frequently Asked Questions

  • When was Immusoft founded?

    Immusoft was founded in 2009.

  • Who are Immusoft key executives?

    Immusoft's key executives are Wendell King, Matthew Scholz and Sean Ainsworth.

  • How many employees does Immusoft have?

    Immusoft has 15 employees.

  • Who are Immusoft competitors?

    Competitors of Immusoft include Scenic Biotech, Poseida Therapeutics and Eloxx Pharmaceuticals.

  • Where is Immusoft headquarters?

    Immusoft headquarters is located at 454 N 34th St, Seattle.

  • Where are Immusoft offices?

    Immusoft has an office in Seattle.

  • How many offices does Immusoft have?

    Immusoft has 1 office.